Evidence map›Paper›PMID 20954278›Full record

ArticleWorld journal of gastroenterology2010

Anti-inflammatory effects of Mangifera indica L. extract in a model of colitis.

Lucía Márquez, Beatriz G Pérez-Nievas, Icíar Gárate, Borja García-Bueno, José Lm Madrigal, Luis Menchén, Gabino Garrido, Juan C Leza

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Acute Supplementation of Soluble Mango Leaf Extract (ZynamitePharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Molecular & cellular oncology · 2024
    Article
  5. Article
  6. Mango (Molecules (Basel, Switzerland) · 2021
    Review
  7. Metabolomic Profiling of Mango (Molecules (Basel, Switzerland) · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. An Evidence-Based Study on Medicinal Plants for Hemorrhoids in Medieval Persia.Journal of evidence-based complementary & alternative medicine · 2017
    Review
  12. Review
  13. A Review on Ethnopharmacological Applications, Pharmacological Activities, and Bioactive Compounds ofEvidence-based complementary and alternative medicine : eCAM · 2017
    Review
  14. Article
  15. Article
  16. The standard aqueous stem bark extract of Mangifera indica L. inhibits toxic PLA2 - NN-XIb-PLA2 of Indian cobra venom.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lucía MárquezDepartment of Pharmacology, School of Medicine, University Complutense and Centro de Investigación en Red de Salud Mental (CIBERSAM), 28040 Madrid, Spain.
Beatriz G Pérez-Nievas
Icíar Gárate
Borja García-Bueno
José Lm Madrigal
Luis Menchén
Gabino Garrido
Juan C Leza

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the effect of aqueous extract from Mangifera indica L. (MIE) on dextran sulfate sodium (DSS)-induced colitis in rats.

methodsMIE (150 mg/kg) was administered in two different protocols: (1) rectally, over 7 d at the same time as DSS administration; and (2) once daily over 14 d (by oral gavage, 7 d before starting DSS, and rectally for 7 d during DSS administration). General observations of clinical signs were performed. Anti-inflammatory activity of MIE was assessed by myeloperoxidase (MPO) activity. Colonic lipid peroxidation was determined by measuring the levels of thiobarbituric acid reactive substances (TBARS). Reduced glutathione (GSH) levels, expression of inflammatory related mediators [inducible isoforms of nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2, respectively] and cytokines [tumor necrosis factor (TNF)-α and TNF receptors 1 and 2] in colonic tissue were also assessed. Interleukin (IL)-6 and TNF-α serum levels were also measured.

resultsThe results demonstrated that MIE has anti-inflammatory properties by improvement of clinical signs, reduction of ulceration and reduced MPO activity when administered before DSS. In addition, administration of MIE for 14 d resulted in an increase in GSH and reduction of TBARS levels and iNOS, COX-2, TNF-α and TNF R-2 expression in colonic tissue, and a decrease in IL-6 and TNF-α serum levels.

conclusionMIE has anti-inflammatory activity in a DSS-induced rat colitis model and preventive administration (prior to DSS) seems to be a more effective protocol.

Indexed as

Administration, OralAdministration, RectalAnimalsAnti-Inflammatory AgentsColitisColonCyclooxygenase 2Dextran SulfateDisease Models, AnimalGastrointestinal AgentsGlutathioneInflammation MediatorsInterleukin-6Lipid PeroxidationMaleMangiferaAnti-Inflammatory AgentsCyclooxygenase 2Dextran SulfateGastrointestinal AgentsGlutathioneInflammation MediatorsInterleukin-6Mangifera indica extractNitric Oxide Synthase Type IINos2 protein, ratPlant ExtractsPtgs2 protein, ratReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIThiobarbituric Acid Reactive SubstancesTnfrsf1a protein, ratTumor Necrosis Factor-alpha

Identifiers

PMID20954278
PMCPMC2957600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.